RVP vs. NSPR, SRTS, INO, MLSS, VANI, CTCX, EDAP, HYPR, APYX, and ZYXI
Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include InspireMD (NSPR), Sensus Healthcare (SRTS), Inovio Pharmaceuticals (INO), Milestone Scientific (MLSS), Vivani Medical (VANI), Carmell (CTCX), Edap Tms (EDAP), Hyperfine (HYPR), Apyx Medical (APYX), and Zynex (ZYXI). These companies are all part of the "medical equipment" industry.
Retractable Technologies vs. Its Competitors
Retractable Technologies (NYSE:RVP) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, community ranking, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.
In the previous week, Retractable Technologies had 1 more articles in the media than InspireMD. MarketBeat recorded 2 mentions for Retractable Technologies and 1 mentions for InspireMD. Retractable Technologies' average media sentiment score of 0.50 beat InspireMD's score of 0.00 indicating that Retractable Technologies is being referred to more favorably in the media.
Retractable Technologies has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500.
Retractable Technologies has a net margin of -41.11% compared to InspireMD's net margin of -413.96%. Retractable Technologies' return on equity of -17.15% beat InspireMD's return on equity.
InspireMD received 5 more outperform votes than Retractable Technologies when rated by MarketBeat users. Likewise, 4.95% of users gave InspireMD an outperform vote while only 0.00% of users gave Retractable Technologies an outperform vote.
7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 57.1% of Retractable Technologies shares are held by company insiders. Comparatively, 34.1% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
InspireMD has a consensus price target of $4.50, indicating a potential upside of 80.00%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than Retractable Technologies.
Retractable Technologies has higher revenue and earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Retractable Technologies beats InspireMD on 11 of the 18 factors compared between the two stocks.
Get Retractable Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Retractable Technologies Competitors List
Related Companies and Tools
This page (NYSE:RVP) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy RVP Stock Free RVP Stock Alerts